Eric Zywicki
Psychiatric/Mental Health · San Bernardino, CANPI 1851801443
Payments from drug & device makers
Across 340 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$817
- Teva Pharmaceuticals USA, Inc.$730
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$676
- Johnson & Johnson$620
- Otsuka America Pharmaceutical, Inc.$562
- Vanda Pharmaceuticals Inc.$506
- plus $3K from 28 others
What the payments were for
- Food & beverage$6,59399%
- Education$811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 44 | $817 |
| Teva Pharmaceuticals USA, Inc. | 35 | $730 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 40 | $676 |
| Johnson & Johnson(2 entities) | 24 | $620 |
| Otsuka America Pharmaceutical, Inc. | 29 | $562 |
| Vanda Pharmaceuticals Inc. | 26 | $506 |
| AbbVie | 20 | $428 |
| Lundbeck LLC | 30 | $396 |
| Axsome Therapeutics, Inc. | 13 | $355 |
| E.r. Squibb & Sons, L.L.C. | 10 | $308 |
| Tris Pharma Inc | 13 | $250 |
| Novartis | 7 | $138 |
| Sunovion Pharmaceuticals Inc. | 12 | $124 |
| Neurocrine Biosciences, Inc. | 4 | $100 |
| Supernus Pharmaceuticals, Inc. | 5 | $97 |
| Incyte Corporation | 4 | $91 |
| Neuronetics, Inc. | 2 | $58 |
| Taiho Oncology, Inc. | 3 | $55 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $49 |
| Astellas Pharma US Inc | 2 | $39 |
| Boehringer Ingelheim | 2 | $29 |
| Rigel Pharmaceuticals, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| AstraZeneca | 1 | $22 |
| Seagen Inc. | 1 | $20 |
| Global Blood Therapeutics, Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Emmaus Medical, Inc. | 1 | $19 |
| EMD Serono, Inc. | 1 | $19 |
| Dova Pharmaceuticals | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $17 |
| Sanofi | 1 | $16 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,674 in reported general payments places this provider in the 90th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 31 | $43,210 |
| Bupropion XlBupropion Hcl | 56 | $2,957 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 16 | $1,486 |
| Trazodone Hcl | 83 | $1,012 |
| Sertraline Hcl | 39 | $645 |
| Hydroxyzine Hcl | 58 | $598 |
| Duloxetine Hcl | 39 | $480 |
| Buspirone Hcl | 50 | $469 |
| Quetiapine Fumarate | 49 | $451 |
| Amitriptyline Hcl | 16 | $292 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 20 | $286 |
| Mirtazapine | 43 | $242 |
| Atomoxetine Hcl | 14 | $182 |
| Prazosin Hcl | 16 | $171 |
| Fluoxetine Hcl | 35 | $143 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $562 | $43,21031 claims |
| Almatica Pharma LLCSertraline Hcl | $17 | $64539 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,433 psychiatric/mental health providers in California.
Other psychiatric/mental health in San Bernardino
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- David OhIrvine$72K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.